Skip to content

Clinical trials

Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Country / region: United States Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20033
20041
20053
20062
20075
20081
20091
20102
20112
20128
20132
20145
20155
20162
20178
20184
20199
20206
202111
20226
20235
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Recruiting20
Active, not recruiting19
Terminated12
Withdrawn2
Unknown status2
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)12
Johns Hopkins University8
Columbia University4
Laboratoires Thea4
jCyte, Inc4
Jaeb Center for Health Research3
Nanoscope Therapeutics Inc.3
Neurotech Pharmaceuticals3
Ocugen3
QLT Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa112
Eye Diseases19
Retinal Diseases19
Usher Syndromes18
Retinal Degeneration14
Macular Degeneration12
Eye Diseases, Hereditary11
Retinal Dystrophies11
Vision Disorders11
Cone-Rod Dystrophies9

Trials

Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.